NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat. - Wikidata - awgldk - TriplyDB

NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat.

NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat.

http://www.wikidata.org/entity/Q37304937

about

The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions Roles and functions of HIV-1 Tat protein in the CNS: an overview A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse cases HIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes.Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals Cooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia.Crosstalk between HDAC6 and Nox2-based NADPH oxidase mediates HIV-1 Tat-induced pro-inflammatory responses in astrocytes.NOX activity is increased in mild cognitive impairment Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration.Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2.Nox-4-dependent nuclear H2O2 drives DNA oxidation resulting in 8-OHdG as urinary biomarker and hemangioendothelioma formation Primary murine microglia are resistant to nitric oxide inhibition of indoleamine 2,3-dioxygenase.Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment.Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages.HIV neuropathogenesis: a tight rope walk of innate immunity.Methionine sulfoxide reductase A negatively controls microglia-mediated neuroinflammation via inhibiting ROS/MAPKs/NF-κB signaling pathways through a catalytic antioxidant function Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia.HIV-1, reactive oxygen species, and vascular complications NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet.Oxidative stress and the HIV-infected brain proteome.CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.Microglial activation and chronic neurodegeneration.Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.Myeloid-specific deletion of NOX2 prevents the metabolic and neurologic consequences of high fat diet.Microglia antioxidant systems and redox signalling.Fate of microglia during HIV-1 infection: From activation to senescence?HIV-1 Tat C modulates NOX2 and NOX4 expressions through miR-17 in a human microglial cell line.ROS upregulation during the early phase of retroviral infection plays an important role in viral establishment in the host cell.Oligomeric Aβ-induced microglial activation is possibly mediated by NADPH oxidase.Childhood maltreatment and HIV-associated neurocognitive disorders share similar pathophysiology: a potential sensitisation mechanism?Molecular mechanisms underlying the involvement of the sigma-1 receptor in methamphetamine-mediated microglial polarization.Altered expression pattern of Nrf2/HO-1 axis during accelerated-senescence in HIV-1 transgenic rat.HIV-Tat elicits microglial glutamate release: role of NAPDH oxidase and the cystine-glutamate antiporter.Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD).15-deoxy-Δ¹²,¹⁴ -prostaglandin J₂ inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome prolifer Neonatal morphine administration leads to changes in hippocampal BDNF levels and antioxidant enzyme activity in the adult life of rats.

P2860

Q26777952-83E9581D-0BEB-47ED-9A9F-DBAD785FDC4D Q26851676-4402CAF6-2EC6-42F0-AB42-5DE019EB809F Q26996314-DDE7F561-6034-403F-9E28-4EB7C1BECF89 Q28477511-BF537A28-4B65-425A-BA07-924CE6DDF399 Q33455734-F9B1FAB7-4B94-4EE2-AD79-5FB5D5771FA9 Q33614467-88B629BA-335C-4108-B13A-3E042236175C Q33647684-E4EB4F3A-2869-4557-81BE-2C46AC2D0666 Q33676138-98622A7B-EADD-49C7-AB00-F7A2E4763935 Q33830110-46CCBD7E-8653-46A7-826D-A5963ABEB482 Q33873538-68879231-6944-441A-9811-D58521C4BC5D Q33931800-DB0E47D4-8B7E-422B-B1A0-1AA1986DBAB1 Q33995740-111EB0D5-22BB-4890-A8D5-ADD669D5C0CA Q34110134-E2079BCA-0799-41FB-9A66-150A8066433E Q34168670-A59C6764-AF32-45EA-8EE3-CF547A048E05 Q34257311-027A49D0-0188-42CF-9FE7-4DFA7C5EAB54 Q34404527-07E84DB6-1F4C-44E2-B09A-FDDABE3AE69C Q35063626-83D7FBA9-7A5C-4CF5-B0AD-A9DE6E17DE0B Q35199303-4C982631-8E05-413A-9760-882843DFCBAA Q35338527-64E416F9-5F6A-4B51-950A-8855C4BAE7E3 Q36040759-FA668697-B300-4895-ACCD-C9C11FCCC1AE Q36593089-8948335A-3728-4A05-8435-CD8E18DD3655 Q37022050-5A6E8522-86D8-494D-B961-B7313F18090F Q37600700-0B381340-35FB-4A55-A67B-EABDCA4DC501 Q37794379-157D48BA-FF90-42DA-A81B-0C3A48492505 Q38009736-BCED7016-1B46-4252-AA8F-6BB7594E077B Q38644482-B113EE41-8F0A-4B75-B0DA-CCFDB005C128 Q38692790-B199B37E-3E07-41C0-AFEF-A62671820308 Q38790617-0C6346FA-8C6C-4CE0-91C5-13BCCC732C89 Q38963813-69BBF9A8-7305-4EA7-8150-0D348B483872 Q39120726-CC0C4850-31D0-4807-B590-B94F2F288C23 Q39228199-82A38205-88D3-4AA8-83D1-17768A69EDD2 Q39417239-C068299D-2E1C-420B-BED8-ACFA1F162739 Q41051944-56345675-7ECA-4960-8E7E-5414DFBAF92E Q42206048-D8F4CA93-8DF7-46C2-B1EF-CF846610C989 Q42408563-664BFD81-AA90-4BCC-96FA-CE2097AAEC1D Q42585205-74E21770-4765-4683-BACC-619660530C65 Q45254835-C53CCEFA-3708-4E6F-B369-D6D5545F4675 Q48260343-5654D98A-6A8A-4E50-B79D-7B17BE56684A

P2860

NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat.

http://www.wikidata.org/entity/Q37304937

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

NADPH oxidase drives cytokine ...... phages in response to HIV-Tat.

@en

NADPH oxidase drives cytokine ...... phages in response to HIV-Tat.

@nl

type

label

NADPH oxidase drives cytokine ...... phages in response to HIV-Tat.

@en

NADPH oxidase drives cytokine ...... phages in response to HIV-Tat.

@nl

prefLabel

NADPH oxidase drives cytokine ...... phages in response to HIV-Tat.

@en

NADPH oxidase drives cytokine ...... phages in response to HIV-Tat.

@nl

P1433

Q37304937-26886374-9CA2-4B15-8235-E0EBF3D6FB73

P1476

Q37304937-8D129F11-373C-4E14-BC18-891EB859CD39

P2093

Q37304937-6B1881B9-7D12-4DEC-B2C4-864664691D4A

Q37304937-9D1B2791-6C3C-41EE-93FA-A2DD5B0FD3F8

Q37304937-B2642B46-4DCC-4A33-8958-B95A278DA821

Q37304937-B7423E4A-5A37-400C-B147-42F5A29F21F6

Q37304937-D48AD752-A64F-4CBB-9451-E81571C588A8

P2860

Q37304937-0A42FADF-780E-4A59-8336-BA288FEFFB59

Q37304937-0FF61F88-B162-463B-96B3-BB7BFC55F38C

Q37304937-106AF94D-DDF8-44FE-A47C-7AEAB68E7B47

Q37304937-11910E3F-1928-40A9-A067-16778D96FB2F

Q37304937-1AD4EFAB-B251-41D9-BD71-07A045821FF4

Q37304937-1C443A1E-6F6E-4214-9A7B-9D8F914961E8

Q37304937-21DBA361-FF7F-4F87-B460-EB7017C5BB23

Q37304937-22DC434F-F7B0-402A-BEC7-D14CC85521FE

Q37304937-26EC9DF7-11F6-4DF9-9DD8-D241C950CB80

Q37304937-277A9D71-0852-461A-BBD3-A684F0AF3474

P304

Q37304937-46C452C2-0C6C-4891-91B3-B2B97B5F9623

P31

Q37304937-98A72279-DB63-4775-AB40-82DEF455D140

P356

Q37304937-CE4677FA-95FB-4CC6-9C47-54936EA6C3EA

P433

Q37304937-14C82FCA-E6D4-46B6-A344-6CD8909B4D88

P478

Q37304937-F29E537B-42EB-4D21-8F05-BF5693DEADDD

P50

Q37304937-130A6BE0-C8C9-483B-8261-DB308718630D

P577

Q37304937-3E3C52CE-C8D0-451B-95CA-099D811F9782

P5875

Q37304937-6ABE69C2-5499-46A5-A15D-3CBC1884AF9D

P698

Q37304937-C6899B26-0FF2-456A-BE43-7E076F96B27F

P921

Q37304937-10ECD53E-0046-4F07-9808-804C3A4F2A66

Q37304937-4F61EA21-96A9-4A3E-B628-A86E15348A38

Q37304937-535DA324-D889-4586-B892-34C53CFAFB91

P932

Q37304937-68C7D94A-EDDA-40AC-ADB9-18D1DE8DCB84

P356

P1433

Antioxidants & Redox Signaling

P1476

NADPH oxidase drives cytokine ...... ophages in response to HIV-Tat

@en

P2093

Annadora J Bruce-Keller

http://www.w3.org/2001/XMLSchema#string

Jadwiga Turchan-Cholewo

http://www.w3.org/2001/XMLSchema#string

R M Charlotte Gorospe

http://www.w3.org/2001/XMLSchema#string

Sunita Gupta

http://www.w3.org/2001/XMLSchema#string

Vanessa M Dimayuga

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state

Free radicals in the physiological control of cell function

Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments

HIV tat and neurotoxicity

The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases

Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions

Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function.

Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain.

Reactive microgliosis.

Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.

P304

193-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/ARS.2008.2097

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23182371

http://www.w3.org/2001/XMLSchema#string

P698

18715150

http://www.w3.org/2001/XMLSchema#string

P921

P932

2726794

http://www.w3.org/2001/XMLSchema#string